What do you need?


Online members portal


ABPI members can log in for bespoke content and services


For the Chance

Millions of people wouldn't be here today if it wasn't for life-changing science. And many more wouldn't be living the lives they do.

Play video


11 April 2019

ABPI reaction to Brexit extension

In light of the Government's announcement of an extension to article 50, ABPI commented on the position regarding stockpiling of medicines in preparation for a 'no-deal'. 


13 March 2019

'Avoid a 'no deal' Brexit' says UK pharma

“Pharmaceutical companies have done everything in their power to prepare for a ‘no deal’ Brexit. This includes increasing stocks of medicines, changing and adding new supply routes and duplicating manufacturing processes here and in Europe." MORE >

08 March 2019

MSD, King's College London and Wellcome agree landmark deal on pain research

King’s College London, Wellcome and pharmaceutical company MSD announced a collaboration and licencing deal today that could lead to a new class of pain medications.

27 February 2019

Government publishes new plans for rare diseases

The Department of Health and Social Care today published the 2019 update of their Implementation Plan for England for the UK Strategy for Rare Diseases. This sets out progress made against the original commitments in the Strategy. 




17 April 2019

Pioneering improvements in laboratory animal welfare – putting the 3Rs into action

The ABPI sponsors the Andrew Blake Tribute Award, which recognises the significant contributions of animal technologists to improving laboratory animal welfare. This year we congratulate Stephen Woodley and Stuart Newman for winning the 2019 Award.  

21 March 2019

Collaborative working between pharma and the NHS works for patients

The ABPI and Health Innovation Manchester were shortlisted for ‘Best Pharmaceutical Partnership’ in the HSJ partnership awards last night. Partnership working with the NHS is the way forward, says ABPI Chief Executive Mike Thompson.